Opaleye Management Inc.
Top Portfolio Positions
53 positions ·
$743,833,828 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| HROW |
Harrow, Inc.
Healthcare
|
2,832,230 | $99,864,429 | 13.43% |
| LQDA |
Liquidia Corp
Healthcare
|
2,545,000 | $96,048,300 | 12.91% |
| ETON |
Eton Pharmaceuticals, Inc.
Healthcare
|
2,860,000 | $70,584,800 | 9.49% |
| SLGL |
Sol-Gel Technologies Ltd.
Healthcare
|
500,000 | $39,610,000 | 5.33% |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
390,000 | $32,826,300 | 4.41% |
| IRON |
Disc Medicine, Inc.
Healthcare
|
421,000 | $26,918,740 | 3.62% |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
1,430,000 | $25,711,400 | 3.46% |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
1,312,615 | $24,112,737 | 3.24% |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
700,000 | $22,792,000 | 3.06% |
| CATX |
Perspective Therapeutics, Inc.
Healthcare
|
4,675,000 | $19,494,750 | 2.62% |
Portfolio Trend
Holdings in BDSX
1 of 1 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,451,681 | 238,047 | Shares | Sole | 2026-05-15 | |
| No quarters match your search. | ||||||